 | • レポートコード：MRC2312MG00723 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のフルオシノロンアセトニド硝子体内インプラント市場規模と予測を収録しています。・世界のフルオシノロンアセトニド硝子体内インプラント市場：売上、2018年-2023年、2024年-2029年 ・世界のフルオシノロンアセトニド硝子体内インプラント市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のフルオシノロンアセトニド硝子体内インプラント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.18mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 フルオシノロンアセトニド硝子体内インプラントのグローバル主要企業は、Auxilium Pharma、 Bausch + Lomb、 EyePoint Pharmaceuticals、 OcuMensionなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、フルオシノロンアセトニド硝子体内インプラントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のフルオシノロンアセトニド硝子体内インプラント市場：タイプ別、2018年-2023年、2024年-2029年 世界のフルオシノロンアセトニド硝子体内インプラント市場：タイプ別市場シェア、2022年 ・0.18mg、0.19mg、0.59mg 世界のフルオシノロンアセトニド硝子体内インプラント市場：用途別、2018年-2023年、2024年-2029年 世界のフルオシノロンアセトニド硝子体内インプラント市場：用途別市場シェア、2022年 ・病院、クリニック 世界のフルオシノロンアセトニド硝子体内インプラント市場：地域・国別、2018年-2023年、2024年-2029年 世界のフルオシノロンアセトニド硝子体内インプラント市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル売上、2018年-2023年 ・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル売上シェア、2022年 ・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル販売量、2018年-2023年 ・主要企業におけるフルオシノロンアセトニド硝子体内インプラントのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Auxilium Pharma、 Bausch + Lomb、 EyePoint Pharmaceuticals、 OcuMension ************************************************************* ・調査・分析レポートの概要 フルオシノロンアセトニド硝子体内インプラント市場の定義 市場セグメント 世界のフルオシノロンアセトニド硝子体内インプラント市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のフルオシノロンアセトニド硝子体内インプラント市場規模 世界のフルオシノロンアセトニド硝子体内インプラント市場規模：2022年 VS 2029年 世界のフルオシノロンアセトニド硝子体内インプラント市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのフルオシノロンアセトニド硝子体内インプラントの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のフルオシノロンアセトニド硝子体内インプラント製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：0.18mg、0.19mg、0.59mg フルオシノロンアセトニド硝子体内インプラントのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック フルオシノロンアセトニド硝子体内インプラントの用途別グローバル売上・予測 ・地域別市場分析 地域別フルオシノロンアセトニド硝子体内インプラント市場規模 2022年と2029年 地域別フルオシノロンアセトニド硝子体内インプラント売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Auxilium Pharma、 Bausch + Lomb、 EyePoint Pharmaceuticals、 OcuMension ... |
This research report provides a comprehensive analysis of the Fluocinolone Acetonide Intravitreal Implant market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fluocinolone Acetonide Intravitreal Implant market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fluocinolone Acetonide Intravitreal Implant, challenges faced by the industry, and potential opportunities for market players.
The global Fluocinolone Acetonide Intravitreal Implant market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fluocinolone Acetonide Intravitreal Implant market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fluocinolone Acetonide Intravitreal Implant market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fluocinolone Acetonide Intravitreal Implant market was valued at US$ 174.5 million in 2022 and is projected to reach US$ 231.9 million by 2029, at a CAGR of 4.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Fluocinolone Acetonide Intravitreal Implant market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fluocinolone Acetonide Intravitreal Implant market.
Market Overview: The report provides a comprehensive overview of the Fluocinolone Acetonide Intravitreal Implant market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 0.18 mg, 0.19 mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fluocinolone Acetonide Intravitreal Implant market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fluocinolone Acetonide Intravitreal Implant market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fluocinolone Acetonide Intravitreal Implant market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fluocinolone Acetonide Intravitreal Implant market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fluocinolone Acetonide Intravitreal Implant market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fluocinolone Acetonide Intravitreal Implant market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fluocinolone Acetonide Intravitreal Implant, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fluocinolone Acetonide Intravitreal Implant market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fluocinolone Acetonide Intravitreal Implant market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
0.18 mg
0.19 mg
0.59 mg
Market segment by Application
Hospital
Clinic
Global Fluocinolone Acetonide Intravitreal Implant Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Auxilium Pharma
Bausch + Lomb
EyePoint Pharmaceuticals
OcuMension
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fluocinolone Acetonide Intravitreal Implant, market overview.
Chapter 2: Global Fluocinolone Acetonide Intravitreal Implant market size in revenue and volume.
Chapter 3: Detailed analysis of Fluocinolone Acetonide Intravitreal Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fluocinolone Acetonide Intravitreal Implant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fluocinolone Acetonide Intravitreal Implant capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Fluocinolone Acetonide Intravitreal Implant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fluocinolone Acetonide Intravitreal Implant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fluocinolone Acetonide Intravitreal Implant Overall Market Size
2.1 Global Fluocinolone Acetonide Intravitreal Implant Market Size: 2022 VS 2029
2.2 Global Fluocinolone Acetonide Intravitreal Implant Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fluocinolone Acetonide Intravitreal Implant Sales: 2018-2029
3 Company Landscape
3.1 Top Fluocinolone Acetonide Intravitreal Implant Players in Global Market
3.2 Top Global Fluocinolone Acetonide Intravitreal Implant Companies Ranked by Revenue
3.3 Global Fluocinolone Acetonide Intravitreal Implant Revenue by Companies
3.4 Global Fluocinolone Acetonide Intravitreal Implant Sales by Companies
3.5 Global Fluocinolone Acetonide Intravitreal Implant Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fluocinolone Acetonide Intravitreal Implant Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fluocinolone Acetonide Intravitreal Implant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fluocinolone Acetonide Intravitreal Implant Players in Global Market
3.8.1 List of Global Tier 1 Fluocinolone Acetonide Intravitreal Implant Companies
3.8.2 List of Global Tier 2 and Tier 3 Fluocinolone Acetonide Intravitreal Implant Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fluocinolone Acetonide Intravitreal Implant Market Size Markets, 2022 & 2029
4.1.2 0.18 mg
4.1.3 0.19 mg
4.1.4 0.59 mg
4.2 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue & Forecasts
4.2.1 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2023
4.2.2 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2024-2029
4.2.3 By Type – Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
4.3 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales & Forecasts
4.3.1 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2023
4.3.2 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2024-2029
4.3.3 By Type – Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
4.4 By Type – Global Fluocinolone Acetonide Intravitreal Implant Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fluocinolone Acetonide Intravitreal Implant Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue & Forecasts
5.2.1 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2023
5.2.2 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2024-2029
5.2.3 By Application – Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
5.3 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales & Forecasts
5.3.1 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2023
5.3.2 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2024-2029
5.3.3 By Application – Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
5.4 By Application – Global Fluocinolone Acetonide Intravitreal Implant Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fluocinolone Acetonide Intravitreal Implant Market Size, 2022 & 2029
6.2 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue & Forecasts
6.2.1 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2023
6.2.2 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue, 2024-2029
6.2.3 By Region – Global Fluocinolone Acetonide Intravitreal Implant Revenue Market Share, 2018-2029
6.3 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales & Forecasts
6.3.1 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2023
6.3.2 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales, 2024-2029
6.3.3 By Region – Global Fluocinolone Acetonide Intravitreal Implant Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.4.2 By Country – North America Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.4.3 US Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.4.4 Canada Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.4.5 Mexico Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.5.2 By Country – Europe Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.5.3 Germany Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.4 France Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.5 U.K. Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.6 Italy Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.7 Russia Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.8 Nordic Countries Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.5.9 Benelux Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.6.2 By Region – Asia Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.6.3 China Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.4 Japan Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.5 South Korea Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.6 Southeast Asia Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.6.7 India Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.7.2 By Country – South America Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.7.3 Brazil Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.7.4 Argentina Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fluocinolone Acetonide Intravitreal Implant Sales, 2018-2029
6.8.3 Turkey Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8.4 Israel Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8.5 Saudi Arabia Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
6.8.6 UAE Fluocinolone Acetonide Intravitreal Implant Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Auxilium Pharma
7.1.1 Auxilium Pharma Company Summary
7.1.2 Auxilium Pharma Business Overview
7.1.3 Auxilium Pharma Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.1.4 Auxilium Pharma Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.1.5 Auxilium Pharma Key News & Latest Developments
7.2 Bausch + Lomb
7.2.1 Bausch + Lomb Company Summary
7.2.2 Bausch + Lomb Business Overview
7.2.3 Bausch + Lomb Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.2.4 Bausch + Lomb Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.2.5 Bausch + Lomb Key News & Latest Developments
7.3 EyePoint Pharmaceuticals
7.3.1 EyePoint Pharmaceuticals Company Summary
7.3.2 EyePoint Pharmaceuticals Business Overview
7.3.3 EyePoint Pharmaceuticals Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.3.4 EyePoint Pharmaceuticals Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.3.5 EyePoint Pharmaceuticals Key News & Latest Developments
7.4 OcuMension
7.4.1 OcuMension Company Summary
7.4.2 OcuMension Business Overview
7.4.3 OcuMension Fluocinolone Acetonide Intravitreal Implant Major Product Offerings
7.4.4 OcuMension Fluocinolone Acetonide Intravitreal Implant Sales and Revenue in Global (2018-2023)
7.4.5 OcuMension Key News & Latest Developments
8 Global Fluocinolone Acetonide Intravitreal Implant Production Capacity, Analysis
8.1 Global Fluocinolone Acetonide Intravitreal Implant Production Capacity, 2018-2029
8.2 Fluocinolone Acetonide Intravitreal Implant Production Capacity of Key Manufacturers in Global Market
8.3 Global Fluocinolone Acetonide Intravitreal Implant Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fluocinolone Acetonide Intravitreal Implant Supply Chain Analysis
10.1 Fluocinolone Acetonide Intravitreal Implant Industry Value Chain
10.2 Fluocinolone Acetonide Intravitreal Implant Upstream Market
10.3 Fluocinolone Acetonide Intravitreal Implant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fluocinolone Acetonide Intravitreal Implant Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
